Wednesday, 16 January 2019

Australia News

  • Novogen progresses on drugs against genetic, degenerative disorders

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2013

    Singapore: Australian company Novogen, engaged in a pilot program aimed at breakthrough development of drugs to treat a wide range of genetic and non-genetic degenerative diseases, has met ...Read more

  • It's all in the genes!

    Australia |  News | By Aishwarya Venkatesh  | 0 Comment | 19 Aug, 2016

    Singapore: WHO estimates that globally, nearly 350 million people suffer from depression. As explained by the health governing bodies, depression is a common illness worldwide and is differ...Read more

  • Lab-to-market is a challenge for Aussie researchers

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 12 Oct, 2012

    Australia: Mr David Henderson, MD of UniQuest, which is one of the technology transfer companies in the Asia Pacific region, believes that tech transfer organizations act as the pivotal poi...Read more

  • Vaxxas' painless vaccine delivery tech fetches BioSpectrum award

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Prof Mark Kendall, a scientist at the Australian Institute of Bioengineering and Nanotechnology under University of Queensland, came up with the idea of nanopatch technology in 2003. The te...Read more

  • Bone Medical reveals results of arthritis study

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2013

    Singapore: Australia-based Bone Medical, a biopharmaceutical company focused on the development of new medicines for musculoskeletal diseases, revealed its initial findings from a proof-of-...Read more

  • Stem cell study reveals potential diabetes cure

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2012

    Singapore: A research conducted by Australian scientists on stem cells has shown that patients suffering from type 1 diabetes have the ability to make their own insulin thus erasing the nee...Read more

  • Aussie firm grows human tendons in lab

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 10 Nov, 2014

    Australia: Australia based regenerative medicine company, Orthocell, has successfully grown human tendons in a laboratory. The research was conducted in collaboration between Orthocell, Un...Read more

  • Australia announces victory over AIDS

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jul, 2016

    Singapore: Ahead of the 21st International AIDS Conference, a team of Australian researchers and experts from the Australian Federation of Aids Organisations have made an announcement stati...Read more

  • There's still time to stop TPP from cutting off critical affordable generic medicines: MSF

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2016

    Singapore: As representatives from the United States and 11 other Pacific-Rim countries gather in New Zealand to sign the Trans-Pacific Partnership (TPP) trade agreement today, the fight to...Read more

  • Luye Medical integrates Australia's Healthe Care to its group

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 May, 2016

    Healthe Care, Australia's third largest private healthcare group, officially became a member of Singapore-headquartered, Luye Medical Group Pte Ltd after the AU $938 million acquisition fro...Read more

  • India, Australia partner to foster sugar research

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 04 May, 2016

    Singapore: Sugar Research Australia recently announced a new research partnership with India to further research and foster the development of new sugarcane varieties. The team aims to focu...Read more

  • QRxPharma, FDA clarify steps for Moxduo release

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

    Singapore: QRxPharma has clarified with the US FDA about the steps necessary for approval of immediate release Moxduo. QRxPharma will resubmit its NDA this quarter, with an expected new PD...Read more

  • Australia's power woman Deborah Rathjen wins BioSpectrum award

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Steering Bionomics' focus towards large markets where there is a defined clinical need for new treatments, Dr Rathjen helped it gain global recognition for its multiple drug candidates and ...Read more

  • Cytori, Lorem to commercialize Cytori Cell Therapy

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Nov, 2013

    Singapore: US-based Cytori Therapeutics and China-based Lorem Vascular have formed a partnership to commercialize Cytori Cell Therapy for the cardiovascular, renal and diabetes markets in C...Read more

  • Australian TGA nod for superbug antibiotic

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Apr, 2013

    Singapore: An effective new antibiotic designed to specifically treat Clostridium difficile-associated diarrhoea will be available to patients in Australia from 14th May 2013. Specialized T...Read more

  • Generon initiates phase I clinical study for F-652 in Australia

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: Generon (Shanghai)has initiated phase I clinical trial for F-652 in Australia. F-652 is a recombinant protein containing a human interleukin-22 (IL-22) dimer. The current phase I...Read more

  • Aus drug delivery technology gets Chinese patent

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2013

    Singapore: Australian drug delivery technology company Imugene has received key Chinese patent application for the company's novel drug delivery technology Linguet. The Chinese application...Read more

  • Post-chemotherapy pain killer trial begins

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2012

    Singapore: Spinifex Pharmaceuticals, an Australian pain drug development company, announced that the first set of patients have been treated in its phase II study of EMA401 in chemotherapy...Read more

Survey Box

Are Healthcare institutions in Asia reporting business improvements after adopting digital tools?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls